< Back to companies

OxSonics Therapeutics’ proprietary platform technology, SonoTran®enables the increased distribution of anti-cancer drugs in solid tunours by increasing their dose

Only accessible to MedStartr community members. Join now

Company Info

Founded
2013
Website
oxsonics.com/

Categories

TherapeuticsCancerDrug DevelopmentDevice Development
Only accessible to MedStartr community members. Join now

What do you think of OxSonics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now